crispr-cas9 crrna (Integrated DNA Technologies)
95
Structured Review
Integrated DNA Technologies
crispr-cas9 crrna
Crispr Cas9 Crrna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 95/100, based on 724 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr-cas9-crrna/CRISPR-Cas9+crRNA/custom%40crispr-cas9-crrna%4042830950
Average 95 stars, based on 724 article reviews
Crispr Cas9 Crrna, supplied by Integrated DNA Technologies, used in various techniques. Bioz Stars score: 95/100, based on 724 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/crispr-cas9-crrna/CRISPR-Cas9+crRNA/custom%40crispr-cas9-crrna%4042830950
Average 95 stars, based on 724 article reviews
crispr-cas9 crrna - by Bioz Stars,
2026-10
95/100 stars
Images
Related Articles
Membrane:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Incubation:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Transfection:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Oligomer Restriction:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Software:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Ubiquitin Proteomics:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Sequencing:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Amplification:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Activated Clotting Time Assay:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( DNA Sequencing:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Concentration Assay:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Blocking Assay:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Disruption:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Knock-Out:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( Gene Knockout:Article Title: Pharmacological Myristoylation Inhibition by Zelenirstat Disrupts Growth Signalling, Energy Metabolism, and Migration in Triple-Negative Breast Cancer Cells Article Snippet: ormal and transferred onto a 0.2 μm PVDF membrane. Antibody blotting was performed as described previously. Guide RNAs targeting human NDUFAF4 were prepared using Alt-R CRISPR-Cas9 tracrRNA, ATTO-550 ( |